Genmab A/S (GNMSF)
337.00
+9.30
(+2.84%)
USD |
OTCM |
Aug 25, 16:00
Genmab Debt to Equity Ratio : 0.8852 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.8852 |
| March 31, 2026 | 0.9417 |
| December 31, 2025 | 0.928 |
| September 30, 2025 | 0.0247 |
| June 30, 2025 | 0.0279 |
| March 31, 2025 | 0.027 |
| December 31, 2024 | 0.028 |
| September 30, 2024 | 0.0309 |
| June 30, 2024 | 0.0329 |
| March 31, 2024 | 0.0311 |
| December 31, 2023 | 0.0244 |
| September 30, 2023 | 0.0255 |
| June 30, 2023 | 0.0279 |
| March 31, 2023 | 0.0305 |
| December 31, 2022 | 0.0219 |
| September 30, 2022 | 0.0236 |
| June 30, 2022 | 0.0259 |
| March 31, 2022 | 0.0183 |
| December 31, 2021 | 0.0191 |
| September 30, 2021 | 0.0205 |
| June 30, 2021 | 0.0219 |
| March 31, 2021 | 0.0188 |
| December 31, 2020 | 0.0167 |
| September 30, 2020 | 0.0182 |
| June 30, 2020 | 0.0199 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0121 |
| December 31, 2019 | 0.0129 |
| September 30, 2019 | 0.0151 |
| June 30, 2019 | 0.0234 |
| March 31, 2019 | 0.0245 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.0001 |
| June 30, 2015 | 0.0001 |
| March 31, 2015 | 0.0001 |
| December 31, 2014 | 0.0002 |
| September 30, 2014 | 0.0002 |
| June 30, 2014 | 0.0003 |
| March 31, 2014 | 0.0003 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Ascendis Pharma A/S | 0.3133 |
| Zealand Pharma A/S | 0.0228 |
| Bavarian Nordic A/S | 0.0099 |
| Evaxion AS | 0.7455 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 12.52B |
| Total Liabilities (Quarterly) | 6.558B |
| Shareholders Equity (Quarterly) | 5.957B |
| Current Ratio | 2.457 |
| Net Debt Paydown Yield | -6.25% |